Liling Zhang

机构：Union Hospital, Jiujiang University, Sun Yat-sen University, Southwest Medical University, Affiliated Hospital of Southwest Medical University, Guangdong Provincial Hospital of Traditional Chinese Medicine, The First Affiliated Hospital, Sun Yat-sen University, Wuhan Union Hospital, Union Hospital, Huazhong University of Science and Technology · ORCID：0000-0002-0198-2603

发表论文 325 篇 · 总被引 6823 次 · h-index 43

代表论文

• Survival Benefit of Adjuvant Radiation Therapy Following Asparaginase-Based Chemotherapy in Patients With Chemoresponsive Advanced-Stage Extranodal NK/T Cell Lymphoma: A Multicenter Study Using the China Lymphoma Collaborative Group Database (2025 · International Journal of Radiation Oncology*Biology*Physics · 被引 4)
• LBA7 Disitamab vedotin (DV) plus toripalimab (T) versus chemotherapy (C) in first-line (1L) locally advanced or metastatic urothelial carcinoma (la/mUC) with HER2-expression (2025 · Annals of Oncology · 被引 4)
• Efficacy and safety of tazemetostat, an EZH2 inhibitor, in Chinese patients with relapsed/refractory follicular lymphoma: a multicentre, single-arm, phase 2 study (2025 · EClinicalMedicine · 被引 3)
• Multiple drug resistance caused by germline mutation of exon 27 of BRCA2 gene in triple-negative breast cancer: a case report and literature review (2025 · Frontiers in Oncology · 被引 3)
• Phase 2 multicenter maintenance study of golidocitinib, A JAK1 selective inhibitor, in patients with peripheral T cell lymphomas after first-line systemic therapy (JACKPOT26) (2026 · Blood Cancer Journal · 被引 2)
• Mutation Profiling, Efficacy Monitoring, and Prognosis Evaluation Using Circulating Tumor DNA in Peripheral T ‐Cell Lymphoma: A Prospective, Multicenter, Observational Study (2026 · American Journal of Hematology · 被引 1)